Gene polymorphisms and therapy in rheumatoid arthritis
Authors:
- 17 February 2016
- journal article
- Published by Informa Healthcare in Expert Opinion on Drug Metabolism & Toxicology
- Vol. 12 (3) , 225-229
Abstract
Rheumatoid arthritis (RA) is a chronic inflammatory and autoimmune disease characterized by the progressive destruction of the joints. RA is associated with increased morbidity and mortality. The d...Keywords
Funding Information
- “ Fondo de Investigaciones Sanitarias„ FEDER (Spain); RETICS Program (RIER) from Instituto de Salud Carlos III, Spain. (PI12/01578; RD08/0075 and RD12/0009/0013.)
This publication has 15 references indexed in Scilit:
- The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapyExpert Opinion on Drug Metabolism & Toxicology, 2015
- Predictors of Response to TNF AntagonistsCurrent Pharmaceutical Design, 2014
- Rheumatoid Arthritis: Genetic Variants as Biomarkers of Cardiovascular DiseaseCurrent Pharmaceutical Design, 2014
- Genetic polymorphisms affect efficacy and adverse drug reactions of DMARDs in rheumatoid arthritisPharmacogenetics and Genomics, 2014
- Pharmacogenetics and Pharmacogenomics for Rheumatoid Arthritis Responsiveness to Methotrexate Treatment: The 2013 UpdatePharmacogenomics, 2014
- Pharmacogenetics and pharmacogenomics in rheumatologyImmunologic Research, 2013
- Pharmacogenetics in Treatment of Rheumatoid ArthritisCurrent Pharmaceutical Design, 2010
- Epidemiology of adult rheumatoid arthritisAutoimmunity Reviews, 2005
- Different gene loci within the HLA‐DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patientsTissue Antigens, 2000
- The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritisArthritis & Rheumatism, 1987